SAN FRANCISCO, Dec 11, 2017 /PRNewswire/ — Aeonian Pharmaceuticals, Inc. (“Aeonian”), a San Francisco Bay Area-based biopharmaceutical company, announced today the closing of a seed financing round. The financing was led by Apollo Ventures, a Life Sciences Venture Capital firm and Life…
